Healthcare & Life Sciences
Syntax Bio
United States
Syntax Bio is a Healthcare & Life Sciences startup based in the United States, most recent round Series A, 2 tracked investors.
activeseries-a
series-a
Stage
2
Investors
About Syntax Bio
Syntax Bio is a company headquartered in the United States. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Syntax Bio develops faster methods for cell therapy by using transient plasmids to deliver CRISPR-based instructions that accelerate stem cell differentiation, making cell therapies more affordable and accessible.
Explore Syntax Bio's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.